| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |